Associated Banc Corp Sells 1,066 Shares of Colgate-Palmolive (NYSE:CL)

Associated Banc Corp lowered its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 1.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 76,344 shares of the company’s stock after selling 1,066 shares during the quarter. Associated Banc Corp’s holdings in Colgate-Palmolive were worth $7,925,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in CL. Gordian Advisors LLC purchased a new stake in Colgate-Palmolive during the 3rd quarter valued at $602,000. Carrera Capital Advisors lifted its holdings in shares of Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after acquiring an additional 7,353 shares during the last quarter. Vontobel Holding Ltd. boosted its stake in shares of Colgate-Palmolive by 224.6% during the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after purchasing an additional 550,750 shares during the period. PGGM Investments grew its holdings in Colgate-Palmolive by 171.8% during the 2nd quarter. PGGM Investments now owns 157,608 shares of the company’s stock valued at $15,294,000 after purchasing an additional 99,624 shares during the last quarter. Finally, QRG Capital Management Inc. raised its position in Colgate-Palmolive by 11.2% in the 2nd quarter. QRG Capital Management Inc. now owns 57,275 shares of the company’s stock worth $5,558,000 after purchasing an additional 5,751 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Up 0.5 %

Shares of Colgate-Palmolive stock traded up $0.50 on Monday, reaching $95.42. The stock had a trading volume of 261,456 shares, compared to its average volume of 4,364,833. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30. The company has a 50 day moving average price of $98.10 and a 200 day moving average price of $98.57. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock has a market capitalization of $77.96 billion, a P/E ratio of 27.20, a P/E/G ratio of 3.39 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.10%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.37% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on CL. Redburn Atlantic upgraded Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. Morgan Stanley boosted their price objective on Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a report on Monday, July 29th. Piper Sandler began coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 target price on the stock. UBS Group boosted their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Finally, Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $105.11.

Get Our Latest Report on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.